ACELLULAR PERTUSSIS VACCINES
- 1 April 2000
- journal article
- review article
- Published by Elsevier in Pediatric Clinics of North America
- Vol. 47 (2) , 309-335
- https://doi.org/10.1016/s0031-3955(05)70209-1
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccineThe Lancet, 1997
- Unchanged efficacy of a pertussis toxoid vaccine throughout the two years after the third vaccination of infantsThe Pediatric Infectious Disease Journal, 1997
- Safety and immunogenicity of acellular pertussis vaccine, combined with diphtheria and tetanus as the Japanese commercial Takeda vaccine, compared with the Takeda acellular pertussis component combined with Lederleʼs diphtheria and tetanus toxoids in two-, four- and six-month-old infantsThe Pediatric Infectious Disease Journal, 1992
- Antibody response to Bordetella pertussis antigens after immunization with American and Canadian whole-cell vaccinesThe Journal of Pediatrics, 1992
- Comparison of acellular and whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infantsThe Journal of Pediatrics, 1991
- Comparison of an acellular pertussis-component diphtheria-tetanus-pertussis (DTP) vaccine with a whole-cell pertussis-component DTP vaccine in 17- to 24-month-old children, with measurement of 69-kilodalton outer membrane protein antibodyThe Journal of Pediatrics, 1990
- Protection Against Pertussis by Acellular Pertussis Vaccines (Takeda, Japan): Household Contact Studies in Kawasaki City, JapanPediatrics International, 1989
- Pertussis Vaccines in JapanPediatrics International, 1988
- Immunization System in Japan: Its History and Present SituationPediatrics International, 1988
- PLACEBO-CONTROLLED TRIAL OF TWO ACELLULAR PERTUSSIS VACCINES IN SWEDEN—PROTECIVE EFFICACY AND ADVERSE EVENTSThe Lancet, 1988